Bavarian Nordic A/S

Founded in 1994, we have more than 25 years of experience in developing life-saving vaccines. We are a global leader in smallpox and mpox vaccines. Our commercial product portfolio contains market-leading vaccines against rabies and tick-borne encephalitis and an Ebola vaccine. We are a global company headquartered in Denmark with a state-of-the-art production facility and sites in Germany, Switzerland, and USA.